8,469 Shares in Waters Co. (NYSE:WAT) Purchased by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in Waters Co. (NYSE:WAT) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 8,469 shares of the medical instruments supplier’s stock, valued at approximately $2,909,000.

Several other hedge funds have also recently bought and sold shares of the company. Kennebec Savings Bank acquired a new stake in shares of Waters during the 3rd quarter worth approximately $33,000. Ashton Thomas Securities LLC bought a new stake in Waters during the third quarter worth $35,000. Fortitude Family Office LLC boosted its holdings in shares of Waters by 235.7% in the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 66 shares in the last quarter. R Squared Ltd bought a new position in shares of Waters in the 4th quarter valued at $63,000. Finally, Itau Unibanco Holding S.A. raised its holdings in shares of Waters by 63.2% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after buying an additional 72 shares in the last quarter. 94.01% of the stock is owned by institutional investors.

Waters Stock Performance

NYSE WAT opened at $382.45 on Thursday. The company has a market capitalization of $22.71 billion, a price-to-earnings ratio of 36.49, a PEG ratio of 7.37 and a beta of 1.01. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56. The stock has a fifty day simple moving average of $390.16 and a 200 day simple moving average of $363.86.

Waters (NYSE:WAT) last issued its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 49.93% and a net margin of 21.43%. Sell-side analysts expect that Waters Co. will post 11.79 EPS for the current year.

Analyst Ratings Changes

WAT has been the topic of several research analyst reports. Wells Fargo & Company raised their price objective on Waters from $380.00 to $415.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Bank of America raised their price target on shares of Waters from $400.00 to $430.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Sanford C. Bernstein raised shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target on the stock in a report on Friday, January 10th. Cfra set a $389.00 price objective on shares of Waters in a research note on Thursday, October 17th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Ten equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Waters has an average rating of “Hold” and an average target price of $388.64.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.